A Unified Model: Chromatin-Bound Multicomponent Condensates

Area of Science:

• Cell biology
• Molecular oncology
• Biophysics

Background:

• Biomolecular condensates are essential for cellular function and implicated in cancer pathogenesis.
• Mutations like NPM1c drive acute myeloid leukemias (AMLs) through condensate formation.

Purpose of the Study:

• To investigate the role of NPM1c in forming nuclear condensates (C-bodies) in AML.
• To explore the function and therapeutic potential of targeting these NPM1c-driven condensates.

Main Methods:

• Cellular studies of NPM1c condensation and co-partitioning of transcriptional coactivators.
• Systematic deletion analysis of NPM1c regions.
• Biophysical comparison of different onco-condensates.

Main Results:

• NPM1c is necessary and sufficient for forming C-bodies, which sequester key coactivators like NUP98, KMT2A/MLL1, Menin, and XPO1/CRM1.
• Inhibiting components within C-bodies alters their function; NPM1c region deletions impact condensate formation.
• C-bodies and other cancer-related condensates (e.g., from NUP98 or KMT2A/MLL1 fusions) are biophysically similar, suggesting a shared pathogenic mechanism.

Conclusions:

• NPM1c-driven C-bodies are critical for AML.
• Cancer-associated condensates represent a shared pathogenic mechanism across various genetic drivers.
• Targeting these chromatin-bound onco-condensates could lead to broad-spectrum cancer therapies.